Who is at highest risk for complications from Shingles vaccine?
According to the product insert for Zostavax contraindications to receiving this vaccine include:
- Individuals with a history of anaphylactic/anaphylactoid reactions to any ingredient in the vaccine, such as gelatin, neomycin, or any other component of the vaccine. See What is Shingles Vaccine for more information on ingredients;
- Individuals who are immunosuppressed or immunodeficient; and
- Individuals who are pregnant – pregnancy should be avoided for 3 months following vaccination. There is insufficient data on the risks and impacts of this vaccine on pregnant women.1
According to the product insert for Shingrix contraindications to receiving this vaccine is a history of severe allergic reactions to any component of the vaccine - See What is Shingles Vaccine? for more information on ingredients. The product insert also states that while some animal studies have been conducted, there is no data to establish vaccine associated risks on the use of Shingrix in pregnant women.2
IMPORTANT NOTE: NVIC encourages you to become fully informed about Shingles and the Shingles vaccine by reading all sections in the Table of Contents , which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.
« Return to Vaccines & Diseases Table of Contents
1 FDA. Zostavax (Frozen). Product Information Sheet. Mar. 21, 2018.
2 FDA. SHINGRIX. Product Information Sheet. Oct. 20, 2017.